These results support the view that the combination of HMGA1 and MPZL1 may be a potential biomarker as they act in a complementary way, predicting recurrent HCC with an AUC of 0.807 (95% CI = 0.681–0.899). The gene discussed is MPZL1; the disease is hepatocellular carcinoma.